Epitel Inc., based in Salt Lake City, specializes in developing advanced wearable technology for epilepsy monitoring and control. Their flagship product, Epilog, is a non-invasive, 24/7 seizure detection system that uses EEG (electroencephalogram) to record and monitor seizure activity. Designed for continuous use, Epilog can be worn at home, during sleep, or on the go, providing users and their healthcare providers with accurate, real-time data to better understand and manage epilepsy. The device is wireless, utilizing Bluetooth technology, and is easy to use with a simple adhesive application and rechargeable battery. Although still in development and not yet FDA-approved, Epilog aims to offer a medical-grade solution that empowers individuals with epilepsy by delivering personalized, long-term brain health insights. Epitel's business model focuses on creating a subscription-based service for continuous monitoring and data analytics, targeting individuals with epilepsy, their families, and healthcare providers. The company operates in the medical device and health technology market, aiming to generate revenue through device sales and ongoing subscription fees for data services.

Keywords: wearable technology, EEG, seizure detection, epilepsy management, brain health, non-invasive, wireless monitoring, personalized insights, medical device, health technology.